Normal lives for people with autoimmune diseases
Autoimmune diseases occur when the immune system is unable to distinguish between harmful pathogens and the body’s own healthy tissues. These diseases target both specific organs and broader bodily systems.
Immunovant’s two investigational product candidates, batoclimab (“IMVT-1401”) and IMVT-1402, are novel, fully human monoclonal antibodies targeting the neonatal Fc receptor (FcRn). We believe that each of these product candidates has the potential to address a variety of IgG-mediated autoimmune diseases as a self-administered subcutaneous injection.Read More